Page last updated: 2024-12-08

picrotin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Picrotin is a natural product isolated from the roots of Picrorhiza kurroa. It has shown diverse pharmacological properties, including antioxidant, anti-inflammatory, hepatoprotective, and neuroprotective effects. Picrotin is known to inhibit the activity of the enzyme xanthine oxidase, which plays a role in the production of reactive oxygen species. This inhibition contributes to its antioxidant properties. Picrotin has also been shown to reduce inflammation by inhibiting the production of pro-inflammatory cytokines. In addition, Picrotin exhibits hepatoprotective activity by protecting liver cells from damage induced by various toxins. Notably, Picrotin has been studied for its potential neuroprotective effects, as it has been shown to protect neurons from damage caused by oxidative stress and neurotoxicity. The compound is also being investigated for its anti-cancer properties. Picrotin has been shown to inhibit the growth of cancer cells in vitro and in vivo. Its potential for therapeutic applications in treating a range of diseases has led to ongoing research and development efforts.'

picrotin: the less toxic component of PICROTOXIN lacking GABA activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

picrotin : An organic heteropentacyclic compound that is picrotoxinin in which the olefinic double bond has undergone addition of water to give the corresponding tertiary alcohol. It is the less toxic component of picrotoxin, lacking GABA activity. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID442291
CHEMBL ID478523
CHEBI ID8205
SCHEMBL ID1688919
MeSH IDM0367454

Synonyms (63)

Synonym
1-hydroxy-14-(2-hydroxypropan-2-yl)-13-methyl-4,7,10-trioxapentacyclo[6.4.1.19,12.03,5.05,13]tetradecane-6,11-dione
nsc-129536
DIVK1C_000756
KBIO1_000756
SDCCGMLS-0066351.P001
SPECTRUM_000413
SPECTRUM4_001781
BSPBIO_001885
SPECTRUM5_000421
nsc 129536
3,6-methano-8h-1,5,7-trioxacyclopenta(ij)cycloprop(a)azulene-4,8(3h)-dione, hexahydro-2a-hydroxy-9-(1-hydroxy-1-methylethyl)-8b-methyl-, (1ar-(1a alpha,2a beta,3beta,6beta,6a beta,8as*,8b beta,9s*))-
picrotin (van)
brn 5302552
picrotin (from anamirta cocculus seed)
ai3-41570
21416-53-5
picrotin
C09528
KBIOSS_000893
KBIO3_001105
KBIO2_003461
KBIO2_006029
KBIO2_000893
KBIOGR_002323
SPECTRUM2_000279
SPECTRUM3_000073
SPBIO_000158
NINDS_000756
SPECTRUM100346
SMP1_000239
IDI1_000756
NCGC00142523-02
HMS502F18
bdbm50269961
HMS1922N10
chebi:8205 ,
CHEMBL478523 ,
NCGC00017246-02
ST057242 ,
(5s,8s,12s,14s,1r,3r,9r,13r)-1-hydroxy-14-(1-hydroxy-isopropyl)-13-methyl-4,7, 10-trioxapentacyclo[6.4.1.1<9,12>.0<3,5>.0<5,13>]tetradecane-6,11-dione
dsstox_gsid_45605
dsstox_rid_80998
tox21_111261
cas-124-87-8
tox21_110806
dsstox_cid_25605
unii-u06z6qd7n2
3,6-methano-8h-1,5,7-trioxacyclopenta(ij)cycloprop(a)azulene-4,8(3h)-dione, hexahydro-2a-hydroxy-9-(1-hydroxy-1-methylethyl)-8b-methyl-, (1ar,2ar,3s,6r,6as,8as,8br,9s)-
u06z6qd7n2 ,
CCG-39837
gtpl4286
picrotin [mi]
(1r,3r,5s,8s,9r,12s,13r,14s)-1-hydroxy-14-(2-hydroxypropan-2-yl)-13-methyl-4,7,10-trioxapentacyclo[6.4.1.1(9,12).0(3,5).0(5,13)]tetradecane-6,11-dione
SCHEMBL1688919
AKOS024282616
Q-100267
DTXSID80274161
mfcd00868514
pikrotin
Q27088386
(1r,3r,5s,8s,9r,12s,13r,14s)-1-hydroxy-14-(2-hydroxypropan-2-yl)-13-methyl-4,7,10-trioxapentacyclo[6.4.1.19,12.03,5.05,13]tetradecane-6,11-dione
NCGC00142523-04
MS-24507

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
organic heteropentacyclic compound
epoxideAny cyclic ether in which the oxygen atom forms part of a 3-membered ring.
tertiary alcoholA tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.
gamma-lactoneA lactone having a five-membered lactone ring.
diolA compound that contains two hydroxy groups, generally assumed to be, but not necessarily, alcoholic. Aliphatic diols are also called glycols.
picrotoxane sesquiterpenoidA group of sesquiterpenoids whose structure is based on a hexahydroindane skeleton, as exemplified by picrotin.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glycine receptor subunit alpha-2Rattus norvegicus (Norway rat)IC50 (µMol)117.30000.00150.80445.0740AID357441
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (27)

Assay IDTitleYearJournalArticle
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID357440Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 300 uM glycine-elicited current at 3 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357462Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as change in relative area of rising time constant of glycine response at 300 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357452Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as shortened single receptor burst opening in response to glycine-pulse at 30 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357444Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 30 uM glycine-elicited current at 300 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357461Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as change in rising time constant of glycine response at 300 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357449Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 300 uM glycine-elicited current at 100 uM at -50 mV voltage by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357467Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as shortened deactivation phase of glycine-evoked response at 100 uM administered before glycine challenge by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID357441Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 300 uM glycine-elicited current by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357453Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as flickering of channel in response to glycine-pulse at 30 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID357455Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as decrease in channel mean open time at 30 uM by outside patch clamp technique relative to control2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357456Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as decrease in channel mean open time by outside patch clamp technique relative to control2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID357445Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 30 uM glycine-elicited current at 300 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357465Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as glycine-evoked response at 100 uM administered before glycine challenge by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357458Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as decrease in activation phase of glycine response at 30 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357448Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 300 uM glycine-elicited current at 100 uM at +50 mV voltage by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357450Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of deactivation time constant by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (13.33)18.7374
1990's0 (0.00)18.2507
2000's3 (20.00)29.6817
2010's9 (60.00)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.88 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]